Sort
40,608 grants matching “prostate cancer”
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis
$442,678Rhonda Szczesniak · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL
Tumor Detection and Classification using QUS Technology's Structure Function
$442,644William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
Community Outreach and Engagement
$442,638Roshan Bastani · University Of California Los Angeles · P30 · FY2020 · CA
Ultrasound Contrast Agents for Inflammation and Angiogenesis
$442,600Joshua J. Rychak · Targeson, Inc. · R44 · FY2010 · EB
Instrumental Variable Methods for Censored Cost Data and an Application in Prosta
$442,540Anirban Basu · University Of Washington · R01 · FY2012 · CA
Engineering and Evaluation of Human L-Methionase for Cancer Therapy
$442,512George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2011 · CA
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers
$442,496John A. Katzenellenbogen · University Of Illinois At Urbana-Champaign · R01 · FY2013 · CA
Ultrasound imaging and enhanced therapeutic response
$442,475Katherine W Ferrara · University Of California At Davis · R01 · FY2014 · CA
Drug Discovery
$442,451Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2017 · MD
Cancer in adults following in utero and early life exposure to arsenic
$442,424Craig M Steinmaus · University Of California Berkeley · R01 · FY2018 · ES
Leveraging deep learning for markerless motion management in radiation therapy
$442,403Lei Xing · Stanford University · R01 · FY2021 · CA
Elucidating the Molecular Basis of Cellular Metal Stress by using Mass Spectrometry-Based Proteomic Methods
$442,309Katherine J. Franz · Duke University · R01 · FY2025 · GM
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va
$442,239Matthew O'Donnell · University Of Washington · R01 · FY2016 · EB
Targeting MUC1-C with an antibody drug conjugate for the therapy of advanced prostate cancer
$442,214Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2022 · CA
Modulators of Prostate Cancer Metastasis
$442,179Bruce R Zetter · Boston Children'S Hospital · R37 · FY2010 · CA
GLUCOCORTICOIDS &VITAMIN D: ROLE IN ANTI-TUMOR EFFECTS
$442,141Roswell Park Cancer Institute Corp · R01 · FY2003 · CA
Targeting NSD1 in leukemia
$442,141Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Epidemiologic and Basic Science in Cancer Prevention
$442,139James Marshall · Roswell Park Cancer Institute Corp · R25 · FY2008 · CA
Real-time monitoring of circulating pancreatic tumor cells and clusters
$442,133Erica Carpenter · University Of Pennsylvania · R01 · FY2018 · CA
Molecular Determinants of Response and Resistance to EZH2 and PARP inhibition in Prostate Cancer
$442,125Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2024 · CA
PathCAM: connecting the digital data pipeline in diagnostic pathology with onboard-camera variable resolution slide imaging
$442,090Jonathan Quincy Brown · Tulane University Of Louisiana · R01 · FY2022 · GM
Deep Learning Methods for Improving Gallium 68-Based PET Imaging
$442,037Kuang Gong · University Of Florida · R01 · FY2024 · EB
Dissecting and Predicting Lethal Prostate Cancer using Biologically Informed Artificial Intelligence
$442,025Eliezer M Van Allen · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$441,967Stephen Matthew Hatfield · Northeastern University · R01 · FY2024 · EB
Targeting NSD1 in leukemia
$441,957Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2023 · CA